Home >> Life Sciences >> Healthcare

Global and United States Specialist Medication In-Depth Research Report 2017-2022

Published: Aug-2017 | Format: PDF | United States Market Insight | Number of pages: 121 | Code: MRS - 168245

The report is based on the market historical data from 2012 to 2016 and forecast the market trend from 2017 to 2022.

This report focuses on the U.S. market and presents volume and value of market share by players, by regions, by product type, by consumers and also changes in prices. As an in-depth report, it covers all details inside analysis and opinions in Specialist Medication industry.

Major Companies
    3D IMAGING DRUG
    ACTELION PHARMS LTD
    BIOMEDCL RES FDN
    Chushin Pharmaceutical Co.,Ltd
    COLGATE PALMOLIVE
    Conba Pharmaceutical Co.,Ltd. Zhejiang
    D'Tang Pharmaceutical Co.,Ltd. Yunnan
    Er-Kang Pharmaceutical Co.,Ltd. Hunan
    ESSENTIAL ISOTOPES
    FRESENIUS KABI USA
    GE HEALTHCARE
    HOT SHOTS NM LLC
    HOUSTON CYCLOTRON
    KREITCHMAN PET CTR
    LUKARE MEDICAL LLC
    Merz Pharmaceuticals GmbH
    MIDWEST MEDCL
    MIPS CRF
    PETNET
    PRECISION NUCLEAR
    Santen Pharmaceutical Co.,Ltd.
    SHOWA YAKUHIN KAKO CO., LTD.
    SPECTRON MRC LLC
    Sterreichische Ichthyol-Gesellschaft m.b.H. nunmehr KG AT 6100 Seefeld
    TRIAD ISOTOPES INC
    UNIV TX MD ANDERSON
    wall Pharmaceutical Co., Ltd. Wuhan
    Wellso Pharmaceutical Co., Ltd. Beijing
    Xinning Pharmaceutical Co.,Ltd. Taishan
    ZEVACOR PHARMA INC

Key Regions
    North America
        United States
            California
            Texas
            New York
            Others
        Canada
    Latin America
        Mexico
        Brazil
        Argentina
        Others
    Europe
        Germany
        United Kingdom
        France
        Italy
        Spain
        Russia
        Netherland
        Others
    Asia & Pacific
        China
        Japan
        India
        Korea
        Australia
        Southeast Asia
            Indonesia
            Thailand
            Philippines
            Vietnam
            Singapore
            Malaysia
            Others
    Africa & Middle East
        South Africa
        Egypt
        Turkey
        Saudi Arabia
        Iran
        Others

Main types of products
Specialist Medication Market, by Radioisotope Medicine
    Trisodium Phosphate
    Sodium Chromate
    Thallium Chloride
    Indium Trichloride
    Liquid Xenon
    Exametazime
Specialist Medication Market, by Oral Medicine
    Alchlor
    Sodium Fluoride
    Rice Bran Sterol
    Cydiodine
Specialist Medication Market, by Surgical Medicine
    Allantoin
    Silver Nitrate
    Paraformaldehyde
    Aluminium Sulfate
    Calcium sulfate
    Turpentine
    Lead Acetate Test Paper
    Ichthammol
    Neurotropin
    Dextranomer

Specialist Medication Market, by Key Consumers
    Department of Radiology
    Department of Stomatology
    Department of Surgery

Table of Contents

Global and United States Specialist Medication In-Depth Research Report 2017-2022
Chapter One Global Specialist Medication Market Overview
    1.1 Global Specialist Medication Market Sales Volume Revenue and Price 2012-2017
    1.2 Specialist Medication, by Radioisotope Medicine 2012-2017
        1.2.1 Global Specialist Medication Sales Market Share by Radioisotope Medicine 2012-2017
        1.2.2 Global Specialist Medication Revenue Market Share by Radioisotope Medicine 2012-2017
        1.2.3 Global Specialist Medication Price by Radioisotope Medicine 2012-2017
        1.2.4 Trisodium Phosphate
        1.2.5 Sodium Chromate
        1.2.6 Thallium Chloride
        1.2.7 Indium Trichloride
        1.2.8 Liquid Xenon
              Exametazime
    1.3 Specialist Medication, by Oral Medicine 2012-2017
        1.3.1 Global Specialist Medication Sales Market Share by Oral Medicine 2012-2017
        1.3.2 Global Specialist Medication Revenue Market Share by Oral Medicine 2012-2017
        1.3.3 Global Specialist Medication Price by Oral Medicine 2012-2017
        1.3.4 Alchlor
        1.3.5 Sodium Fluoride
        1.3.6 Rice Bran Sterol
        1.3.7 Cydiodine
    1.4 Specialist Medication, by Surgical Medicine 2012-2017
        1.4.1 Global Specialist Medication Sales Market Share by Surgical Medicine 2012-2017
        1.4.2 Global Specialist Medication Revenue Market Share by Surgical Medicine 2012-2017
        1.4.3 Global Specialist Medication Price by Surgical Medicine 2012-2017
        1.4.4 Allantoin
        1.4.5 Silver Nitrate
        1.4.6 Paraformaldehyde
        1.4.7 Aluminium Sulfate
        1.4.8 Calcium sulfate
              Turpentine
              Lead Acetate Test Paper
              Ichthammol
              Neurotropin
              Dextranomer

Chapter Two United States Specialist Medication Market Overview
    2.1 United States Specialist Medication Market Sales Volume Revenue and Price 2012-2017
    2.2 Specialist Medication, by Radioisotope Medicine 2012-2017
        2.2.1 United States Specialist Medication Sales Market Share by Radioisotope Medicine 2012-2017
        2.2.2 United States Specialist Medication Revenue Market Share by Radioisotope Medicine 2012-2017
        2.2.3 United States Specialist Medication Price by Radioisotope Medicine 2012-2017
        2.2.4 Trisodium Phosphate
        2.2.5 Sodium Chromate
        2.2.6 Thallium Chloride
        2.2.7 Indium Trichloride
        2.2.8 Liquid Xenon
              Exametazime
    2.3 Specialist Medication, by Oral Medicine 2012-2017
        2.3.1 United States Specialist Medication Sales Market Share by Oral Medicine 2012-2017
        2.3.2 United States Specialist Medication Revenue Market Share by Oral Medicine 2012-2017
        2.3.3 United States Specialist Medication Price by Oral Medicine 2012-2017
        2.3.4 Alchlor
        2.3.5 Sodium Fluoride
        2.3.6 Rice Bran Sterol
        2.3.7 Cydiodine
    2.4 Specialist Medication, by Surgical Medicine 2012-2017
        2.4.1 United States Specialist Medication Sales Market Share by Surgical Medicine 2012-2017
        2.4.2 United States Specialist Medication Revenue Market Share by Surgical Medicine 2012-2017
        2.4.3 United States Specialist Medication Price by Surgical Medicine 2012-2017
        2.4.4 Allantoin
        2.4.5 Silver Nitrate
        2.4.6 Paraformaldehyde
        2.4.7 Aluminium Sulfate
        2.4.8 Calcium sulfate
              Turpentine
              Lead Acetate Test Paper
              Ichthammol
              Neurotropin
              Dextranomer

Chapter Three Specialist Medication by Regions 2012-2017
    3.1 Global Specialist Medication Sales Market Share by Regions 2012-2017
    3.2 Global Specialist Medication Revenue Market Share by Regions 2012-2017
    3.3 Global Specialist Medication Price by Regions 2012-2017
    3.4 North America
        3.4.1 United States
            3.4.1.1 California
            3.4.1.2 Texas
            3.4.1.3 New York
            3.4.1.4 Others in United States
        3.4.2 Canada
    3.5 Latin America
        3.5.1 Mexico
        3.5.2 Brazil
        3.5.3 Argentina
        3.5.4 Others in Latin America
    3.6 Europe
        3.6.1 Germany
        3.6.2 United Kingdom
        3.6.3 France
        3.6.4 Italy
        3.6.5 Spain
        3.6.6 Russia
        3.6.7 Netherland
        3.6.8 Others in Europe
    3.7 Asia & Pacific
        3.7.1 China
        3.7.2 Japan
        3.7.3 India
        3.7.4 Korea
        3.7.5 Australia
        3.7.6 Southeast Asia
            3.7.6.1 Indonesia
            3.7.6.2 Thailand
            3.7.6.3 Philippines
            3.7.6.4 Vietnam
            3.7.6.5 Singapore
            3.7.6.6 Malaysia
            3.7.6.7 Others in Southeast Asia
    3.8 Africa & Middle East
        3.8.1 South Africa
        3.8.2 Egypt
        3.8.3 Turkey
        3.8.4 Saudi Arabia
        3.8.5 Iran
        3.8.6 Others in Africa & Middle East

Chapter Four Global Specialist Medication by Companies 2012-2017
    4.1 Global Specialist Medication Sales Volume Market Share by Companies 2012-2017
    4.2 Global Specialist Medication Revenue Share by Companies 2012-2017
    4.3 Global Top Companies Specialist Medication Key Product Model and Market Performance
    4.4 Global Top Companies Specialist Medication Key Target Consumers and Market Performance

Chapter Five United States Specialist Medication by Companies 2012-2017
    5.1 United States Specialist Medication Sales Volume Market Share by Companies 2012-2017
    5.2 United States Specialist Medication Revenue Share by Companies 2012-2017
    5.3 United States Top Companies Specialist Medication Key Product Model and Market Performance
    5.4 United States Top Companies Specialist Medication Key Target Consumers and Market Performance

Chapter Six Global Specialist Medication by Consumer 2012-2017
    6.1 Global Specialist Medication Sales Market Share by Consumer 2012-2017
    6.2 Department of Radiology
    6.3 Department of Stomatology
    6.4 Department of Surgery
    6.5 Consuming Habit and Preference

Chapter Seven Global Specialist Medication by Consumer 2012-2017
    7.1 Global Specialist Medication Sales Market Share by Consumer 2012-2017
    7.2 Department of Radiology
    7.3 Department of Stomatology
    7.4 Department of Surgery
    7.5 Consuming Habit and Preference

Chapter Eight Top Companies Profile
    8.1 3D IMAGING DRUG
        8.1.1 3D IMAGING DRUG Company Details and Competitors
        8.1.2 3D IMAGING DRUG Key Specialist Medication Models and Performance
        8.1.3 3D IMAGING DRUG Specialist Medication Business SWOT Analysis and Forecast
        8.1.4 3D IMAGING DRUG Specialist Medication Sales Volume Revenue Price Cost and Gross Margin
    8.2 ACTELION PHARMS LTD
        8.2.1 ACTELION PHARMS LTD Company Details and Competitors
        8.2.2 ACTELION PHARMS LTD Key Specialist Medication Models and Performance
        8.2.3 ACTELION PHARMS LTD Specialist Medication Business SWOT Analysis and Forecast
        8.2.4 ACTELION PHARMS LTD Specialist Medication Sales Volume Revenue Price Cost and Gross Margin
    8.3 BIOMEDCL RES FDN
        8.3.1 BIOMEDCL RES FDN Company Details and Competitors
        8.3.2 BIOMEDCL RES FDN Key Specialist Medication Models and Performance
        8.3.3 BIOMEDCL RES FDN Specialist Medication Business SWOT Analysis and Forecast
        8.3.4 BIOMEDCL RES FDN Specialist Medication Sales Volume Revenue Price Cost and Gross Margin
    8.4 Chushin Pharmaceutical Co.,Ltd
        8.4.1 Chushin Pharmaceutical Co.,Ltd Company Details and Competitors
        8.4.2 Chushin Pharmaceutical Co.,Ltd Key Specialist Medication Models and Performance
        8.4.3 Chushin Pharmaceutical Co.,Ltd Specialist Medication Business SWOT Analysis and Forecast
        8.4.4 Chushin Pharmaceutical Co.,Ltd Specialist Medication Sales Volume Revenue Price Cost and Gross Margin
    8.5 COLGATE PALMOLIVE
        8.5.1 COLGATE PALMOLIVE Company Details and Competitors
        8.5.2 COLGATE PALMOLIVE Key Specialist Medication Models and Performance
        8.5.3 COLGATE PALMOLIVE Specialist Medication Business SWOT Analysis and Forecast
        8.5.4 COLGATE PALMOLIVE Specialist Medication Sales Volume Revenue Price Cost and Gross Margin
    8.6 Conba Pharmaceutical Co.,Ltd. Zhejiang
        8.6.1 Conba Pharmaceutical Co.,Ltd. Zhejiang Company Details and Competitors
        8.6.2 Conba Pharmaceutical Co.,Ltd. Zhejiang Key Specialist Medication Models and Performance
        8.6.3 Conba Pharmaceutical Co.,Ltd. Zhejiang Specialist Medication Business SWOT Analysis and Forecast
        8.6.4 Conba Pharmaceutical Co.,Ltd. Zhejiang Specialist Medication Sales Volume Revenue Price Cost and Gross Margin
    8.7 D'Tang Pharmaceutical Co.,Ltd. Yunnan
        8.7.1 D'Tang Pharmaceutical Co.,Ltd. Yunnan Company Details and Competitors
        8.7.2 D'Tang Pharmaceutical Co.,Ltd. Yunnan Key Specialist Medication Models and Performance
        8.7.3 D'Tang Pharmaceutical Co.,Ltd. Yunnan Specialist Medication Business SWOT Analysis and Forecast
        8.7.4 D'Tang Pharmaceutical Co.,Ltd. Yunnan Specialist Medication Sales Volume Revenue Price Cost and Gross Margin
    8.8 Er-Kang Pharmaceutical Co.,Ltd. Hunan
        8.8.1 Er-Kang Pharmaceutical Co.,Ltd. Hunan Company Details and Competitors
        8.8.2 Er-Kang Pharmaceutical Co.,Ltd. Hunan Key Specialist Medication Models and Performance
        8.8.3 Er-Kang Pharmaceutical Co.,Ltd. Hunan Specialist Medication Business SWOT Analysis and Forecast
        8.8.4 Er-Kang Pharmaceutical Co.,Ltd. Hunan Specialist Medication Sales Volume Revenue Price Cost and Gross Margin
    8.9 ESSENTIAL ISOTOPES
        8.9.1 ESSENTIAL ISOTOPES Company Details and Competitors
        8.9.2 ESSENTIAL ISOTOPES Key Specialist Medication Models and Performance
        8.9.3 ESSENTIAL ISOTOPES Specialist Medication Business SWOT Analysis and Forecast
        8.9.4 ESSENTIAL ISOTOPES Specialist Medication Sales Volume Revenue Price Cost and Gross Margin
    8.10 FRESENIUS KABI USA
        8.10.1 FRESENIUS KABI USA Company Details and Competitors
        8.10.2 FRESENIUS KABI USA Key Specialist Medication Models and Performance
        8.10.3 FRESENIUS KABI USA Specialist Medication Business SWOT Analysis and Forecast
        8.10.4 FRESENIUS KABI USA Specialist Medication Sales Volume Revenue Price Cost and Gross Margin
    8.11 GE HEALTHCARE
    8.12 HOT SHOTS NM LLC
    8.13 HOUSTON CYCLOTRON
    8.14 KREITCHMAN PET CTR
    8.15 LUKARE MEDICAL LLC
    8.16 Merz Pharmaceuticals GmbH
    8.17 MIDWEST MEDCL
    8.18 MIPS CRF
    8.19 PETNET
    8.20 PRECISION NUCLEAR
    8.21 Santen Pharmaceutical Co.,Ltd.
    8.22 SHOWA YAKUHIN KAKO CO., LTD.
    8.23 SPECTRON MRC LLC
    8.24 Sterreichische Ichthyol-Gesellschaft m.b.H. nunmehr KG AT 6100 Seefeld
    8.25 TRIAD ISOTOPES INC
    8.26 UNIV TX MD ANDERSON
    8.27 wall Pharmaceutical Co., Ltd. Wuhan
    8.28 Wellso Pharmaceutical Co., Ltd. Beijing
    8.29 Xinning Pharmaceutical Co.,Ltd. Taishan
    8.30 ZEVACOR PHARMA INC

Chapter Nine Industry Chain and Supply Chain
    9.1 Specialist Medication Industry Chain Structure
        9.1.1 R&D
        9.1.2 Raw Materials (Components)
        9.1.3 Manufacturing Plants
        9.1.4 Regional Trading (Import Export and Local Sales)
        9.1.5 Online Sales Channel
        9.1.6 Offline Channel
        9.1.7 End Users
    9.2 Specialist Medication Manufacturing
        9.2.1 Key Components
        9.2.2 Assembly Manufacturing
    9.3 Consumer Preference
    9.4 Behavioral Habits
    9.5 Marketing Environment

Chapter Ten Global Specialist Medication Market Size (Sales and Revenue) Forecast (2017-2022)
    10.1 Global Specialist Medication Sales (), Revenue (Million USD) Forecast (2017-2022)
    10.2 Global Specialist Medication Sales () Forecast by Regions (2017-2022)
    10.3 Global Specialist Medication Sales () Forecast by Application (2017-2022)
    10.4 Global Specialist Medication Sales () Forecast by Radioisotope Medicine (2017-2022)
    10.5 Global Specialist Medication Sales () Forecast by Oral Medicine (2017-2022)
    10.6 Global Specialist Medication Sales () Forecast by Surgical Medicine (2017-2022)

Chapter Eleven United States Specialist Medication Market Size (Sales and Revenue) Forecast (2017-2022)
    11.1 United States Specialist Medication Sales (), Revenue (Million USD) Forecast (2017-2022)
    11.2 United States Specialist Medication Sales () Forecast by Regions (2017-2022)
    11.3 United States Specialist Medication Sales () Forecast by Application (2017-2022)
    11.4 United States Specialist Medication Sales () Forecast by Radioisotope Medicine (2017-2022)
    11.5 United States Specialist Medication Sales () Forecast by Oral Medicine (2017-2022)
    11.6 United States Specialist Medication Sales () Forecast by Surgical Medicine (2017-2022)

Chapter Twelve Development Trend and Research Conclusion
    12.1 Development Trend
    12.2 Research Conclusion

Chapter Thirteen Methodology and Data Source
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer



                        
            

Inquiry For Buying

Please fill your details below, to inquire about this report:
Indicates required fields

Request Sample

Please fill your details below, to receive sample report:
Indicates required fields


Related Reports

Catenin Beta 1 (Beta Catenin or CTNNB1) - Pipeline Review, H2 2017

Oct-2017 | Global Markets Direct | Pages : 57 | Code : MRS-172735 | 3500

Catenin Beta 1 (Beta Catenin or CTNNB1) - Pipeline Review, H2 2017 Summary Catenin Beta 1 (Beta Catenin or CTNNB1) pipeline Target constitutes close to 14 molecules. Out of which approximately 10 molecules are developed by companies and remaining by the universities/institutes. The latest report Catenin Beta 1 (Beta Catenin or CTNNB1) - Pipeline Review, H2 2017, outlays comprehensive information on the Catenin Beta 1 (Beta Catenin or CTNNB1) targeted therapeutics, complete with analysis b Read more

Transthyretin (ATTR or Prealbumin or TBPA or TTR) - Pipeline Review, H2 2017

Oct-2017 | Global Markets Direct | Pages : 74 | Code : MRS-172734 | 3500

Transthyretin (ATTR or Prealbumin or TBPA or TTR) - Pipeline Review, H2 2017 Summary According to the recently published report 'Transthyretin (ATTR or Prealbumin or TBPA or TTR) - Pipeline Review, H2 2017'; Transthyretin (ATTR or Prealbumin or TBPA or TTR) pipeline Target constitutes close to 15 molecules. Out of which approximately 12 molecules are developed by companies and remaining by the universities/institutes. Transthyretin (ATTR or Prealbumin or TBPA or TTR) - Transthyretin is Read more

Complement C5 (C3 And PZP Like Alpha 2 Macroglobulin Domain Containing Protein 4 or C5) - Pipeline Review, H2 2017

Oct-2017 | Global Markets Direct | Pages : 107 | Code : MRS-172733 | 3500

Complement C5 (C3 And PZP Like Alpha 2 Macroglobulin Domain Containing Protein 4 or C5) - Pipeline Review, H2 2017 Summary Complement C5 (C3 And PZP Like Alpha 2 Macroglobulin Domain Containing Protein 4 or C5) - Complement component 5 is a protein is encoded by the C5 gene. Activation of C5 by a C5 convertase initiates the spontaneous assembly of the late complement components, C5-C9, into the membrane attack complex. C5b has a transient binding site for C6. The C5b-C6 complex is the fou Read more

Protein Kinase C Epsilon Type (nPKC Epsilon or PRKCE or EC 2.7.11.13) - Pipeline Review, H2 2017

Oct-2017 | Global Markets Direct | Pages : 42 | Code : MRS-172732 | 3500

Protein Kinase C Epsilon Type (nPKC Epsilon or PRKCE or EC 2.7.11.13) - Pipeline Review, H2 2017 Summary Protein Kinase C Epsilon Type (nPKC Epsilon or PRKCE or EC 2.7.11.13) pipeline Target constitutes close to 7 molecules. Out of which approximately 7 molecules are developed by Companies. The latest report Protein Kinase C Epsilon Type (nPKC Epsilon or PRKCE or EC 2.7.11.13) - Pipeline Review, H2 2017, outlays comprehensive information on the Protein Kinase C Epsilon Type (nPKC Epsilon Read more

Aurora Kinase C (Aurora 3 or Aurora/IPL1 Related Kinase 3 or Aurora/IPL1/Eg2 Protein 2 or Serine/Threonine Protein Kinase 13 or Serine/Threonine Protein Kinase Aurora C or AURKC or EC 2.7.11.1) - Pipeline Review, H2 2017

Oct-2017 | Global Markets Direct | Pages : 32 | Code : MRS-172731 | 3500

Aurora Kinase C (Aurora 3 or Aurora/IPL1 Related Kinase 3 or Aurora/IPL1/Eg2 Protein 2 or Serine/Threonine Protein Kinase 13 or Serine/Threonine Protein Kinase Aurora C or AURKC or EC 2.7.11.1) - Pipeline Review, H2 2017 Summary According to the recently published report 'Aurora Kinase C - Pipeline Review, H2 2017'; Aurora Kinase C (Aurora 3 or Aurora/IPL1 Related Kinase 3 or Aurora/IPL1/Eg2 Protein 2 or Serine/Threonine Protein Kinase 13 or Serine/Threonine Protein Kinase Aurora C or AUR Read more

Glycogen Synthase Kinase 3 Beta (Serine/Threonine Protein Kinase GSK3B or GSK3B or EC 2.7.11.26 or EC 2.7.11.1) - Pipeline Review, H2 2017

Oct-2017 | Global Markets Direct | Pages : 58 | Code : MRS-172730 | 3500

Glycogen Synthase Kinase 3 Beta (Serine/Threonine Protein Kinase GSK3B or GSK3B or EC 2.7.11.26 or EC 2.7.11.1) - Pipeline Review, H2 2017 Summary Glycogen Synthase Kinase 3 Beta (Serine/Threonine Protein Kinase GSK3B or GSK3B or EC 2.7.11.26 or EC 2.7.11.1) - Glycogen synthase kinase 3 beta also known as GSK3B is an enzyme encoded by the GSK3B. It constitutively activate protein kinase that acts as a negative regulator in the hormonal control of glucose homeostasis, Wnt signaling and reg Read more

Glucokinase (Hexokinase D or Hexokinase 4 or GCK or EC 2.7.1.2) - Pipeline Review, H2 2017

Oct-2017 | Global Markets Direct | Pages : 50 | Code : MRS-172729 | 3500

Glucokinase (Hexokinase D or Hexokinase 4 or GCK or EC 2.7.1.2) - Pipeline Review, H2 2017 Summary Glucokinase (Hexokinase D or Hexokinase 4 or GCK or EC 2.7.1.2) pipeline Target constitutes close to 11 molecules. Out of which approximately 9 molecules are developed by companies and remaining by the universities/institutes. The latest report Glucokinase (Hexokinase D or Hexokinase 4 or GCK or EC 2.7.1.2) - Pipeline Review, H2 2017, outlays comprehensive information on the Glucokinase (Hex Read more

Telomerase Reverse Transcriptase (HEST2 or Telomerase Catalytic Subunit or Telomerase Associated Protein 2 or TERT or EC 2.7.7.49) - Pipeline Review, H2 2017

Oct-2017 | Global Markets Direct | Pages : 112 | Code : MRS-172728 | 3500

Telomerase Reverse Transcriptase (HEST2 or Telomerase Catalytic Subunit or Telomerase Associated Protein 2 or TERT or EC 2.7.7.49) - Pipeline Review, H2 2017 Summary According to the recently published report 'Telomerase Reverse Transcriptase - Telomerase Reverse Transcriptase'; Telomerase Reverse Transcriptase (HEST2 or Telomerase Catalytic Subunit or Telomerase Associated Protein 2 or TERT or EC 2.7.7.49) pipeline Target constitutes close to 31 molecules. Out of which approximately 25 m Read more

Dual Specificity Protein Kinase TTK (Cancer/Testis Antigen 96 or Monopolar Spindle 1 Like 1 or Phosphotyrosine Picked Threonine Protein Kinase or TTK or EC 2.7.12.1) - Pipeline Review, H2 2017

Oct-2017 | Global Markets Direct | Pages : 36 | Code : MRS-172727 | 3500

Dual Specificity Protein Kinase TTK (Cancer/Testis Antigen 96 or Monopolar Spindle 1 Like 1 or Phosphotyrosine Picked Threonine Protein Kinase or TTK or EC 2.7.12.1) - Pipeline Review, H2 2017 Summary Dual Specificity Protein Kinase TTK (Cancer/Testis Antigen 96 or Monopolar Spindle 1 Like 1 or Phosphotyrosine Picked Threonine Protein Kinase or TTK or EC 2.7.12.1) - Dual specificity protein kinase TTK is an enzyme encoded by the TTK gene. It is associated with cell proliferation, essentia Read more

Poly [ADP Ribose] Polymerase 1 (ADP Ribosyltransferase Diphtheria Toxin Like 1 or NAD(+) ADP Ribosyltransferase 1 or Poly[ADP Ribose] Synthase 1 or PARP1 or EC 2.4.2.30) - Pipeline Review, H2 2017

Oct-2017 | Global Markets Direct | Pages : 145 | Code : MRS-172726 | 3500

Poly [ADP Ribose] Polymerase 1 (ADP Ribosyltransferase Diphtheria Toxin Like 1 or NAD(+) ADP Ribosyltransferase 1 or Poly[ADP Ribose] Synthase 1 or PARP1 or EC 2.4.2.30) - Pipeline Review, H2 2017 Summary Poly [ADP Ribose] Polymerase 1 (ADP Ribosyltransferase Diphtheria Toxin Like 1 or NAD(+) ADP Ribosyltransferase 1 or Poly[ADP Ribose] Synthase 1 or PARP1 or EC 2.4.2.30) pipeline Target constitutes close to 31 molecules. Out of which approximately 27 molecules are developed by companies Read more

Single User | $(USD)3190 View Pricing